Medical Science News

RSS

Gene variant predisposes humans to develop acute myeloid leukemia, says study

A large international research group led by Dr. Tarik M-r-y, a researcher at the Institut de recherches cliniques de Montr-al (IRCM), has discovered that a variant of the gene "Growth Factor Independence 1" (GFI1) predisposes humans to develop acute myeloid leukemia (AML), a certain subtype of blood cancer.

20 Jan 2010

Microbiologists explain why apples are beneficial for health

Why does an apple a day keep the doctor away? New research published in the open access journal BMC Microbiology contributes to our understanding of why eating apples is good for you.

20 Jan 2010

Statins may protect SCD children from pneumococcal infection

New research suggests a family of widely used cholesterol-lowering drugs might help protect individuals from serious illness following bacterial infection, including the pneumococcal infections that pose a deadly threat to those with sickle cell disease.

20 Jan 2010

Dynamic mapping may help in detecting links between diseases and environmental exposures

A team of researchers has developed a dynamic mapping tool to gain a more nuanced view of the links between diseases and environmental exposures. The application of the method is illustrated by a number of examples of associations between environmental exposures and Salmonella infections among people in the US age 65 and over in 2002.

20 Jan 2010

Alnylam Pharmaceuticals presents data on multiple therapeutic programs at RNAi Symposium

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today announced that it presented data from multiple pre-clinical and clinical programs at the “RNA Silencing: Mechanism, Biology, and Application” Keystone Symposium held January 14-19, 2010 in Keystone, Colorado. Alnylam and its collaborators presented data from Alnylam’s therapeutic programs including transthyretin (TTR)-mediated amyloidosis and Huntington’s disease, as well as new data on delivery approaches for the systemic delivery of RNAi therapeutics.

20 Jan 2010

Combination treatment strategies may benefit patients with non-small cell lung cancer

Even when their tumors are shrinking in response to therapy, some non-small cell lung cancer (NSCLC) patients have a scattering of cancer cells that are undeterred by the drug, causing the tumor to resume its growth, Dana-Farber Cancer Institute and Massachusetts General Hospital (MGH) Cancer Center scientists report in the January issue of Cancer Cell.

20 Jan 2010

New research at Rhode Island Hospital identifies a treatment for glioblastomas

New research at Rhode Island Hospital has identified a treatment in animal models for glioblastomas - deadly brain tumors which, once diagnosed, offer a poor prognosis and relatively short life expectancy.

20 Jan 2010

Study shows an intriguing relationship between cancer-related genes and schizophrenia susceptibility

People who inherit a specific form of a gene that puts them on a road to schizophrenia may be protected against some forms of cancer, according to a new study by scientists at The Feinstein Institute for Medical Research.

20 Jan 2010

Researchers propose a new model for breast cell differentiation

A study by researchers at Tufts University School of Medicine, the Sackler School of Graduate Biomedical Sciences at Tufts, and Tufts Medical Center improves our current understanding of the origins of breast cancer. The

19 Jan 2010

Repeated exposure to tobacco smoke makes lung cancer much worse

Repeated exposure to tobacco smoke makes lung cancer much worse, and one reason is that it steps up inflammation in the lung. Scientists at the University of California, San Diego School of Medicine have found that mice with early lung cancer lesions that were repeatedly exposed to tobacco smoke developed larger tumors - and developed tumors more quickly - than unexposed animals.

19 Jan 2010

Affomix, City of Hope collaborate in exploring next generation sequencing using digital proteomics

Affomix Corporation, a pioneer in high performance antibody technology, announced today a collaboration with City of Hope focused on establishing the clinical utility of “digital proteomics” with next generation sequencers. One of the nation’s top cancer research and treatment centers, City of Hope is a leading provider of molecular diagnostic testing services and an innovator in clinical genetics research.

19 Jan 2010

Perseid Therapeutics to co-develop and commercialize next-generation CTLA4-Ig therapeutics

Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its majority-owned subsidiary, Perseid Therapeutics LLC, achieved a preclinical milestone under its collaboration with Astellas Pharma Inc. to co-develop and commercialize next-generation CTLA4-Ig therapeutics.

19 Jan 2010

Scarab Genomics launches White Glove IS Detection Kit

Scarab Genomics has now launched the White Glove IS Detection Kit to test for the presence of transposable Insertion Sequence (IS) elements in a DNA of interest. Numerous IS elements are naturally present in the genomes of E. coli strains commonly used for protein and plasmid production, but are not present in the Scarab Genomics Clean Genome® strains.

19 Jan 2010

New functions in an enzyme can develop through point mutation

A new study by a research team at Uppsala University shows how new functions can develop in an enzyme. This can explain, for example, how resistance to toxins can occur so simply. The findings are now being published in the Journal of Biological Chemistry.

19 Jan 2010

TAP and EPSRC Centre for Innovative Manufacturing in Regenerative Medicine continue collaboration

The Automation Partnership (TAP), a world leader in the design and development of innovative automation for life science applications is pleased to announce that its collaboration with leading translational research group, the EPSRC Centre for Innovative Manufacturing in Regenerative Medicine at Loughborough University is to continue into a second five year phase. This follows the recent announcement by Prime Minister, Gordon Brown and Lord Mandelson, UK Secretary of State, Department for Business, Innovation and Skills of a £5.33 million grant to the centre.

19 Jan 2010

Genetic map of Artemisia will accelerate breeding to address increased demand for malaria treatments

Plant scientists at the University of York have published the first genetic map of the medicinal herb Artemisia annua. The map is being used to accelerate plant breeding of Artemisia and rapidly develop the species into a high-yielding crop. This development is urgently needed to help meet escalating demand for effective malaria treatments.

19 Jan 2010

Study provides new insights into genetics and evolution

Researchers from the University of Geneva and the SIB Swiss Institute of Bioinformatics led an analysis of the sequenced genomes of parasitic wasps. Generally unknown to the public, the parasitic wasps kill pest insects. They are like 'smart bombs' that seek out and kill only specific kinds of insects.

19 Jan 2010

The Methodist Hospital initiates program on nanotechnology in orthopedics and spine surgery

A new research program at The Methodist Hospital in Houston is the nation's first dedicated solely to advancing nanotechnology in orthopedics and spine surgery.

19 Jan 2010

EMBL-EBI hosts drug discovery database

ChEMBLdb, a vast online database of information on the properties and activities of drugs and drug-like small molecules and their targets, launches today with information on over half a million compounds. The data lie at the heart of translating information from the human genome into successful new drugs in the clinic.

19 Jan 2010

Journal Homeopathy highlights a remarkable range of findings on homeopathic treatments

The journal Homeopathy (http://www.elsevier.com/locate/homp) has published a two part special issue focusing on biological models of homeopathy. The special issue highlights experiments on homeopathic treatments in biological models, ranging from whole animals and plants to cell cultures and enzymes, showing a remarkable range of findings.

19 Jan 2010

Medical Science News

Gene variant predisposes humans to develop acute myeloid leukemia, says study

Microbiologists explain why apples are beneficial for health

Statins may protect SCD children from pneumococcal infection

Dynamic mapping may help in detecting links between diseases and environmental exposures

Alnylam Pharmaceuticals presents data on multiple therapeutic programs at RNAi Symposium

Combination treatment strategies may benefit patients with non-small cell lung cancer

New research at Rhode Island Hospital identifies a treatment for glioblastomas

Study shows an intriguing relationship between cancer-related genes and schizophrenia susceptibility

Researchers propose a new model for breast cell differentiation

Repeated exposure to tobacco smoke makes lung cancer much worse

Affomix, City of Hope collaborate in exploring next generation sequencing using digital proteomics

Perseid Therapeutics to co-develop and commercialize next-generation CTLA4-Ig therapeutics

Scarab Genomics launches White Glove IS Detection Kit

New functions in an enzyme can develop through point mutation

TAP and EPSRC Centre for Innovative Manufacturing in Regenerative Medicine continue collaboration

Genetic map of Artemisia will accelerate breeding to address increased demand for malaria treatments

Study provides new insights into genetics and evolution

The Methodist Hospital initiates program on nanotechnology in orthopedics and spine surgery

EMBL-EBI hosts drug discovery database

Journal Homeopathy highlights a remarkable range of findings on homeopathic treatments

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News